Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.

Cancer research - 1 Dec 2002

Alli Elizabeth, Bash-Babula Judy, Yang Jin-Ming, Hait William N

Abstract excerpt

Stathmin is a p53-regulated protein known to influence microtubule dynamics. Because several chemotherapeutic agents used to treat breast cancer alter the dynamic equilibrium of tubulin polymerization, stathmin may play an important role in determining the sensitivity to these drugs. Therefore, we evaluated the effect of stathmin expression on the action of taxanes and Vinca alkaloids using a panel of human...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Phytogenic
Share to Cell Cycle
Share to Microtubule Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microtubules

Share to Paclitaxel

Share to Phosphoproteins

Share to Stathmin

Share to Vinblastine

Source

Identifiers

PMID: 12460900

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.PMID 12460900Read ↗

Stathmin expression and its relationship to microtubule‐associated protein tau and outcome in breast cancerSemantic proximity Read ↗

Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53.Semantic proximity Read ↗

The individualization of cancer therapy: the unexpected role of p53.Semantic proximity Read ↗

Effects of stathmin inhibition on the mitotic spindle.Semantic proximity Read ↗

Stathmin: a protein with many tasks. New biomarker and potential target in cancerSemantic proximity Read ↗

Microtubule‐Binding Proteins as Promising Biomarkers of Paclitaxel Sensitivity in Cancer ChemotherapySemantic proximity Read ↗

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.Semantic proximity Read ↗

Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics.Semantic proximity Read ↗

Global regulation of the interphase microtubule system by abundantly expressed Op18/stathmin.Semantic proximity Read ↗

Microtubule Associated Protein (MAP)-Tau: A Novel Mediator of Paclitaxel Sensitivity In Vitro and In VivoSemantic proximity Read ↗

The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells.Semantic proximity Read ↗

Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.